publication . Article . 2015

Exploración de las intervenciones clínicas realizadas por farmacéuticos en un servicio complejo de asma

Lynne Emmerton; Ines Krass; Bandana Saini; Kay Stewart; Deborah Burton; Lorraine Smith; Carol L. Armour; Kate S. LeMay; Sinthia Bosnic-Anticevich;
Open Access
  • Published: 01 Mar 2015
Abstract
Background: Pharmacists in Australia are accessible health care professionals, and their provision of clinical pharmacy interventions in a range of areas has been proven to improve patient outcomes. Individual clinical pharmacy interventions in the area of asthma management have been very successful. An understanding of the nature of these interventions will inform future pharmacy services. What we do not know is when pharmacists provide a complex asthma service, what elements of that service (interventions) they choose to deliver. Objective: To explore the scope and frequency of asthma-related clinical interventions provided by pharmacists to patients in an evi...
Subjects
free text keywords: Original Research, mesh:Asthma, mesh:Pharmaceutical Services, mesh:Pharmacists, mesh:Evidence-Based Practice, mesh:Australia, Asthma, Pharmaceutical Services, Pharmacists, Evidence-Based Practice, Australia, Asma, Servicios Farmacéuticos, Farmacéuticos, Práctica Basada en la Evidencia Practice, lcsh:Therapeutics. Pharmacology, lcsh:RM1-950, lcsh:Pharmacy and materia medica, lcsh:RS1-441, Clinical pharmacy, Nursing Interventions Classification, Family medicine, medicine.medical_specialty, medicine, Pharmacist, Pharmacy, business.industry, business, Nursing, Pharmacy practice, Psychological intervention, Health care
34 references, page 1 of 3

1. Hawksworth G, Corlett A, Wright D, Chrystyn H. Clinical pharmacy interventions by community pharmacists during the dispensing process. Br J Clin Pharmacol. 1999;47(6):695-700.

2. Benrimoj S, Langford J, Berry G, Collins D, Lauchlan R, Stewart K, Ward PR. Clinical significance of clinical interventions in community pharmacy: a randomised trial of the effect of education and a professional allowance. Int J Pharm Pract. 2003;11(2):81-87.

3. Williams K, Emmerton L, Taylor R, Werner J, Benrimoj S. Non-prescription medicines and Australian community pharmacy interventions: rates and clinical significance. Int J Pharm Pract. 2011;19(3):156-165. doi: 10.1111/j.2042- 7174.2010.00091.x [OpenAIRE]

4. Williams M, Peterson G, Tenni P, Bindoff I, Stafford A. DOCUMENT: a system for classifying drug-related problems in community pharmacy. Int J Clin Pharm. 2012;34(1):43-52. doi: 10.1007/s11096-011-9583-1

5. Young S, Bishop L, Conway A. Interventions performed by community pharmacists in once Canadian province: a crosssectinal study. Ther Clin Risk Manag. 2012;8:415-421. doi: 10.2147/TCRM.S37581 [OpenAIRE]

6. Pottegård A, Hallas J, Søndergaard J. Pharmaceutical interventions on prescription problems in a Danish pharmacy setting. Int J Clin Pharm. 2011;33(6):1019-1027. doi: 10.1007/s11096-011-9580-4 [OpenAIRE]

7. Stafford A, Bindoff I, Tenni P, Peterson G, Doran C. A methodological framework for estimating the clinical and economic value of community pharmacists' clinical interventions using expert opinion. J Clin Pharm Ther. 2012;37(4):378-385. doi: 10.1111/j.1365-2710.2011.01322.x

8. Benrimoj S, Langford J, Berry G, Colins D, Lauchlan R, Stewart K, Aristides M, Dobson M. Economic impact of increased clinical intervention rates in community pharmacy. A randomised trial of the effect of education and a professional allowance. Pharmacoeconomics. 2000;18(5):459-468.

9. Rupp M. Value of community pharmacists' interventions to correct prescribing errors. Ann Pharmacother. 1992;26(12):1580-1584.

10. Williams M, Peterson G, Tenni P, Bindoff I, Curtain C, Hughes J, Bereznicki LR, Jackson SL, Kong DC, Hughes JD. Drug-related problems detected in Australian Community Pharmacies: The PROMISe Trial. Ann Pharmacother. 2011 Sp;45(9):1067-1076. doi: 10.1345/aph.1Q138

11. Australian Government Department of Health. 5th Community Pharmacy Agreement. Pharmacy Practice Incentives. Available at: http://5cpa.com.au/programs/pharmacy-practice-incentives/ (Accessed 31 October 2014).

12. Krass I, Hebing R, Mitchell B, Hughes J, Peterson G, Song Y, Stewart K, Armour CL. Diabetes management in an Australian primary care population. J Clin Pharm Ther. 2011;36(6):664-672. doi: 10.1111/j.1365-2710.2010.01221.x

13. Armour CL, Reddel HK, LeMay KS, Saini B, Smith LD, Bosnic-Anticevich SZ, Song YJ, Alles MC, Burton DL, Emmerton L, Stewart K, Krass I. Feasibility and effectiveness of an evidence-based asthma service in Australian community pharmacies: a pragmatic cluster randomised trial. J Asthma. 2013;50(3):302-309. doi: 10.3109/02770903.2012.754463

14. Global Initiative for Asthma. GINA Report. Global Strategy for Asthma Management and Prevention, Available at http://www.ginasthma.org (Accessed: 31 October 2014).

15. Armour CL, Lemay K, Saini B, Reddel HK, Bosnic-Anticevich SZ, Smith LD, Burton D, Song YJ, Alles MC, Stewart K, Emmerton L, Krass I. Using the community pharmacy to identify patients at risk of poor asthma control and factors which contribute to this poor control. J Asthma. 2011;48(9):914-922. doi: 10.3109/02770903.2011.615431

34 references, page 1 of 3
Any information missing or wrong?Report an Issue